Privex Investments

Ideas. Perspective. Progress.

All news bits regarding upcoming IPOs for you

The latest insights and perspectives from Privex Investments.

Explore our thinking

Latest perspectives

2 insights
AI-generated editorial illustration for API Holdings clears ₹1,050 crore debt via Thyrocare stake sale, keeps a 51.02% unpledged holding

Oct 27, 2026 · 3 min read

API Holdings clears ₹1,050 crore debt via Thyrocare stake sale, keeps a 51.02% unpledged holding

API Holdings, the parent of Thyrocare, said it has become debt-free after repaying ₹1,050 crore, ETHealthWorld reported on 18 August 2026. The repayment was funded by selling about 9.90% of Thyrocare and from internal accruals. Its holding company Docon now owns 51.02% of Thyrocare, with the pledge on those shares released, so the group keeps majority control without encumbrance.

Read insight
AI-generated editorial illustration for Integris Medtech trims IPO fresh issue to ₹600 crore from ₹925 crore, with about 85% earmarked for debt

Oct 24, 2026 · 4 min read

Integris Medtech trims IPO fresh issue to ₹600 crore from ₹925 crore, with about 85% earmarked for debt

Integris Medtech has cut the fresh issue in its proposed IPO to ₹600 crore from ₹925 crore, according to a DRHP addendum reported by BusinessLine on October 22, 2026. About ₹509.85 crore is earmarked for repaying subsidiary borrowings. Co-founders Gurmit Singh Chugh and Punita Sharma have withdrawn from the offer for sale, and promoter Evercure Holdings has cut its sale to up to 1.08 crore shares.

Read insight